沿海和海洋生物化学解决方案市场预测至2034年—按产品类型、应用、最终用户和地区分類的全球分析

根据 Stratistics MRC 的数据，预计到 2026 年，全球沿海和海洋生物化学解决方案市场规模将达到 6 亿美元，并在预测期内以 7.0% 的复合年增长率增长，到 2034 年将达到 11 亿美元。

海洋和沿海生物化学解决方案利用海洋生物的独特特性，在医疗保健、农业和个人护理等领域创造永续的创新产品。从藻类、海藻和海洋微生物中提取的生物活性物质可用于改善营养、健康和环境效益。对天然来源和环境友善原材料日益增长的需求正在推动市场的快速成长。先进的生物技术方法和海洋提取过程实现了高效的大规模生产。这些解决方案在负责任地利用海洋资源、促进生态系统保护和最大限度地减少生态足迹方面发挥着至关重要的作用，使沿海和海洋生物化学产品成为永续工业发展的重要组成部分。

根据欧洲海洋生物技术协会（ESMB）的说法，海洋生物技术是欧盟「蓝色成长策略」的重要贡献者。该策略估计，蓝色经济每年创造7,500亿欧元的产值，并支撑着超过500万个就业机会。海洋生物化学解决方案是此生态系统的重要组成部分。

对天然环保成分的需求日益增长

消费者对永续、天然成分的日益关注和偏好正在推动沿海和海洋生物化学市场的成长。在医疗保健、个人护理和农业等领域，源自海藻、藻类和海洋微生物的生物活性化合物正被用作合成产品的替代品。环保法规和永续发展倡议正在促进这些产品的应用，并鼓励企业创新和拓展海洋生物技术。这些海洋来源的成分在提供功能性益处的同时，不会对环境造成负面影响，因此既满足了消费者的需求，也符合企业的永续发展目标。随着各行业认识到天然海洋解决方案在产品差异化和履行环境责任方面的价值，该市场正持续扩张。

高昂的生产和提取成本

海洋生物化学产品的生产受到高昂的营运和提取成本的限制。对先进技术、熟练人员和专用设备的需求增加了成本，使得中小企业难以进行大规模生产。发酵、超临界流体萃取和酵素法加工等方法需要大量投资，推高了产品价格。此外，取得永续来源的藻类和海藻也增加了经济负担。这些飙升的成本可能会阻碍该行业采用海洋来源的化合物，从而可能减缓市场扩张。

对机能性食品和营养保健品的需求不断增长

全球对机能性食品和营养保健品的日益关注，为海洋生物化学解决方案开闢了广阔前景。源自藻类、海藻和海洋微生物的化合物富含抗氧化剂、必需维生素和矿物质，使其成为健康产品的理想原料。消费者对健康、免疫力和营养的日益重视，以及可支配收入的成长，正在推动膳食补充剂和强化食品的需求。製造商可以利用这些海洋来源的生物活性物质，开发创新健康产品。因此，日益增长的健康意识为沿海和海洋生物化学市场带来了巨大的机会，促进了食品和营养保健品行业的研发和扩张。

过度捕捞海洋资源

过度捕捞藻类、海藻和微生物等海洋生物对生态系和生物多样性构成重大威胁。不可持续的做法会导致原材料短缺、成本上升和生产受限。监管限制可能会进一步限制捕捞，并影响供应稳定性。依赖海洋自然资源的公司在註重环保的市场中面临营运中断和声誉受损的风险。这些生态学和监管方面的挑战威胁着市场的稳定和扩张。公司必须采取永续的采购和水产养殖方法来减轻这些威胁。过度开发仍然是一个重大风险，可能会阻碍沿海和海洋生物化学解决方案产业的成长。

新型冠状病毒（COVID-19）的影响：

全球新冠疫情衝击了沿海和海洋生物化学市场，影响了海洋来源原料的生产、供应链和分销。疫情限制和封锁阻碍了海藻、藻类和其他海洋微生物的采集，导致原料供应受限。劳动力短缺和防疫措施也造成了生产基地运作延误。经济的不确定性导致化妆品、保健品和营养保健品等领域的需求下降。另一方面，消费者对免疫力和健康的日益关注也带动了对海洋来源生物活性化合物的需求。因此，儘管疫情暂时抑制了市场成长，但也为开发以健康为导向的功能性海洋生物化学产品创造了机会。

在预测期内，藻类衍生的生化产品领域预计将成为最大的细分市场。

由于藻类衍生生物化学品具有广泛的工业应用，预计在预测期内，该领域将占据最大的市场份额。这些产品提供多醣、色素、抗氧化剂和维生素等重要的生物活性化合物，可用于製药、营养保健品、化妆品和农产品等领域。藻类因其永续、快速生长和易于培养等优点，预计将拥有极高的需求量。这些成分正越来越多地应用于机能性食品、膳食补充剂、护肤品和环保生物基产品。随着萃取和加工技术的不断进步，效率和品质不断提高，藻类衍生生物化学品已成为市场成长和创新的主要驱动力。

在预测期内，医疗保健和生物技术产业预计将呈现最高的复合年增长率。

在预测期内，受医药、治疗和预防医学领域对海洋生物活性化合物需求不断增长的推动，医疗保健生物技术领域预计将呈现最高的成长率。源自藻类、海藻和海洋微生物的化合物可提供重要的抗氧化剂、抗发炎剂和其他功能分子，这些分子对医药和生物技术应用至关重要。人们对健康、免疫力和保健的日益关注正在推动这些化合物的应用，而提取和加工技术的进步则提高了产品品质和扩充性。海洋生物化学品在医疗保健和生物技术领域的应用创造了巨大的成长潜力，使该领域成为市场中成长最快的产业。

市占率最大的地区：

在预测期内，亚太地区预计将占据最大的市场份额，这主要得益于其丰富的海洋资源、完善的水产养殖基础设施以及大规模的海藻和藻类生产。对海洋生物技术的大量投资正在推动生物活性化合物在医药、保健品、化妆品和农业等领域的开发和商业化。消费者对天然和功能性产品的偏好日益增长，加上政府的奖励和永续的资源管理，进一步巩固了该地区的市场主导地位。提取和加工技术的进步，以及不断提高的健康意识和产业发展，确保了稳定的供应和市场渗透率。

复合年增长率最高的地区：

在预测期内，北美地区预计将呈现最高的复合年增长率，这主要得益于该地区对海洋生物技术研发的大量投资。该地区先进的基础设施、高素质的专业人才以及政府的各项倡议，正在推动永续和健康型海洋产品的普及应用。医疗保健、营养保健品和化妆品产业对生物活性化合物的需求不断增长，也促进了市场对这类产品的接受度。提取、加工和配方方面的创新正在提升产品的性能和扩充性。此外，消费者对健康、免疫力和环保产品的日益关注也为市场成长提供了支持。

免费客製化服务：

所有购买此报告的客户均可享受以下免费自订选项之一：

• 企业概况
  • 对其他市场参与者（最多 3 家公司）进行全面分析
  • 对主要企业进行SWOT分析（最多3家公司）
• 区域划分
  • 应客户要求，我们提供主要国家和地区的市场估算和预测，以及复合年增长率（註：需进行可行性检查）。
• 竞争性标竿分析
  • 根据产品系列、地理覆盖范围和策略联盟对主要企业进行基准分析。

目录

第一章执行摘要

• 市场概览及主要亮点
• 驱动因素、挑战与机会
• 竞争格局概述
• 战略洞察与建议

第二章：研究框架

• 研究目标和范围
• 相关人员分析
• 研究假设和限制
• 调查方法

第三章 市场动态与趋势分析

• 市场定义与结构
• 主要市场驱动因素
• 市场限制与挑战
• 投资成长机会和重点领域
• 产业威胁与风险评估
• 技术与创新展望
• 新兴市场/高成长市场
• 监管和政策环境
• 新冠疫情的影响及復苏前景

第四章：竞争环境与策略评估

• 波特五力分析
  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的竞争
• 主要企业市占率分析
• 产品基准评效和效能比较

第五章 全球沿海和海洋生物化学解决方案市场：按产品类型划分

• 海洋酵素
• 藻类衍生的生化产品
• 生物基涂料和腐蚀抑制剂
• 海洋营养保健品和药品

第六章 全球沿海和海洋生物化学解决方案市场：按应用划分

• 海岸修復/环境管理
• 基础设施应用
• 水产养殖/渔业
• 医疗保健和治疗应用

第七章 全球沿海和海洋生物化学解决方案市场：按最终用户划分

• 航运/海洋工程
• 环保组织
• 医疗保健和生物技术
• 食品/饮料

第八章 全球沿海和海洋生物化学解决方案市场：按地区划分

• 北美洲
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲
  • 英国
  • 德国
  • 法国
  • 义大利
  • 西班牙
  • 荷兰
  • 比利时
  • 瑞典
  • 瑞士
  • 波兰
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 韩国
  • 澳洲
  • 印尼
  • 泰国
  • 马来西亚
  • 新加坡
  • 越南
  • 其他亚太国家
• 南美洲
  • 巴西
  • 阿根廷
  • 哥伦比亚
  • 智利
  • 秘鲁
  • 其他南美国家
• 世界其他地区（RoW）
  • 中东
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 以色列
    • 其他中东国家
  • 非洲
    • 南非
    • 埃及
    • 摩洛哥
    • 其他非洲国家

第九章 战略市场资讯

• 工业价值网络和供应链评估
• 空白区域和机会地图
• 产品演进与市场生命週期分析
• 通路、经销商和打入市场策略的评估

第十章：产业趋势与策略倡议

• 併购
• 伙伴关係、联盟和合资企业
• 新产品发布和认证
• 扩大生产能力和投资
• 其他策略倡议

第十一章：公司简介

• BASF SE
• AstaReal Co., Ltd.
• Cyanotech Corporation
• Marinomed Biotech AG
• PharmaMar SA
• Aker BioMarine ASA
• Algatechnologies Ltd
• CP Kelco US, Inc.
• Euglena Co., Ltd.
• GlycoMar Ltd.
• Lonza Group
• Marinova Pty Ltd
• Bluebiotech International GmbH
• Earthrise Nutritionals LLC
• Marine Essence Biosciences
• Coastal BioTech Ltd
• MarineBioGroup
• Biotal Marine

According to Stratistics MRC, the Global Coastal & Marine Biochemical Solutions Market is accounted for $0.6 billion in 2026 and is expected to reach $1.1 billion by 2034 growing at a CAGR of 7.0% during the forecast period. Marine and coastal biochemical solutions leverage the distinct characteristics of ocean-based organisms to create sustainable, innovative products across sectors like healthcare, agriculture, and personal care. Bioactive substances extracted from algae, seaweed, and marine microbes are used to improve nutrition, health, and environmental outcomes. Growing demand for natural and eco-conscious ingredients is driving rapid market growth. Cutting-edge biotechnological methods and marine extraction processes enable efficient large-scale production. These solutions play a vital role in utilizing marine resources responsibly, fostering ecosystem preservation, and minimizing ecological footprints, positioning coastal and marine biochemicals as essential contributors to sustainable industrial development.

According to the European Society for Marine Biotechnology (ESMB), marine biotechnology contributes significantly to the EU's Blue Growth Strategy, which estimates that the blue economy generates €750 billion annually and supports over 5 million jobs. Marine biochemical solutions are a key part of this ecosystem.

Market Dynamics:

Driver:

Rising demand for natural and eco-friendly ingredients

Increasing consumer awareness and preference for sustainable, naturally sourced ingredients is fueling growth in the coastal and marine biochemical market. Sectors including healthcare, personal care, and agriculture are adopting bioactive compounds from seaweed, algae, and marine microbes to replace synthetic alternatives. Eco-friendly regulations and sustainability initiatives support adoption, encouraging companies to innovate and scale marine biotechnology. By providing functional benefits without environmental harm, these marine-derived ingredients satisfy both consumer demand and corporate sustainability goals. The market continues to expand as industries recognize the value of natural marine solutions in achieving product differentiation and environmental responsibility.

Restraint:

High production and extraction costs

Marine biochemical production is constrained by high operational and extraction costs. Advanced technologies, skilled personnel, and specialized equipment increase expenses, making large-scale production challenging for smaller companies. Methods such as fermentation, supercritical fluid extraction, and enzymatic processing require substantial investment, driving up product prices. Additionally, obtaining sustainably sourced algae and seaweed adds to financial burdens. Elevated costs can discourage industries from adopting marine-derived compounds, slowing market expansion.

Opportunity:

Growing demand for functional foods and nutraceuticals

Increasing global interest in functional foods and nutraceuticals provides a promising avenue for marine biochemical solutions. Compounds from algae, seaweed, and marine microbes are packed with antioxidants, essential vitamins, and minerals, making them valuable for health-enhancing products. Growing consumer awareness of wellness, immunity, and nutrition, along with higher disposable incomes, drives demand for dietary supplements and fortified foods. Manufacturers can leverage these marine bioactives to create innovative, health-focused products. The expanding health-conscious population thus offers significant opportunities for the coastal and marine biochemical market, encouraging product development and expansion across food and nutraceutical industries.

Threat:

Overexploitation of marine resources

Excessive extraction of marine organisms like algae, seaweed, and microbes poses significant threats to ecosystems and biodiversity. Unsustainable practices can result in shortages of raw materials, higher costs, and production limitations. Regulatory restrictions may further constrain harvesting, affecting supply reliability. Businesses dependent on wild marine resources risk operational interruptions and reputational damage in environmentally conscious markets. Such ecological and regulatory challenges endanger market stability and expansion. Companies must adopt sustainable sourcing and cultivation approaches to mitigate these threats. Overexploitation remains a critical risk that could hinder growth in the coastal and marine biochemical solutions sector.

Covid-19 Impact:

The global COVID-19 outbreak disrupted the coastal and marine biochemical market by affecting production, supply chains, and distribution of marine-derived ingredients. Restrictions and lockdowns hindered the collection of seaweed, algae, and other marine microorganisms, limiting raw material supplies. Manufacturing faced operational delays due to workforce shortages and health safety measures. Economic uncertainties reduced demand in sectors such as cosmetics, healthcare, and nutraceuticals. At the same time, heightened consumer focus on immunity and wellness increased interest in marine bioactive compounds. Thus, while the pandemic temporarily restrained market growth, it also created opportunities for developing health-oriented and functional marine biochemical products.

The algae-derived biochemicals segment is expected to be the largest during the forecast period

The algae-derived biochemicals segment is expected to account for the largest market share during the forecast period due to their broad industrial applications. They provide essential bioactive compounds such as polysaccharides, pigments, antioxidants, and vitamins, supporting pharmaceuticals, nutraceuticals, cosmetics, and agricultural products. The sustainable nature of algae, combined with fast growth rates and straightforward cultivation, makes them highly desirable. These ingredients are increasingly used in functional foods, dietary supplements, skincare formulations, and eco-friendly bio-based products. Ongoing advancements in extraction and processing techniques have enhanced their efficiency and quality, establishing algae-derived biochemicals as the primary driver of market growth and innovation.

The healthcare & biotechnology segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the healthcare & biotechnology segment is predicted to witness the highest growth rate, driven by rising demand for marine-derived bioactive compounds in medicines, therapeutics, and preventive care. Compounds sourced from algae, seaweed, and marine microorganisms provide critical antioxidants, anti-inflammatory properties, and other functional molecules essential for pharmaceutical and biotech applications. Increased focus on health, immunity, and wellness encourages adoption, while technological advancements in extraction and processing improve product quality and scalability. The application of marine biochemicals in healthcare and biotechnology creates vast growth potential; making this segment the market's most rapidly expanding area.

Region with largest share:

During the forecast period, the Asia-Pacific region is expected to hold the largest market share due to its rich marine resources, extensive aquaculture infrastructure, and large-scale seaweed and algae production. Significant investments in marine biotechnology support the development and commercialization of bioactive compounds across sectors like pharmaceuticals, nutraceuticals, cosmetics, and agriculture. Rising consumer preference for natural and functional products, coupled with government incentives and sustainable resource management, reinforces the region's dominance. Technological advancements in extraction and processing, along with increasing health awareness and industrial growth, ensure steady supply and market adoption.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, driven by substantial investment in marine biotech R&D. The region's advanced infrastructure, skilled professionals, and governmental initiatives promote sustainable and health-oriented marine products. Increasing demand for bioactive compounds in healthcare, nutraceuticals, and cosmetics encourages adoption. Innovations in extraction, processing, and formulation improve product performance and scalability. Additionally, heightened consumer focus on wellness, immunity, and environmentally friendly products supports market growth.

Key players in the market

Some of the key players in Coastal & Marine Biochemical Solutions Market include BASF SE, AstaReal Co., Ltd., Cyanotech Corporation, Marinomed Biotech AG, PharmaMar SA, Aker BioMarine ASA, Algatechnologies Ltd, CP Kelco U.S., Inc., Euglena Co., Ltd., GlycoMar Ltd., Lonza Group, Marinova Pty Ltd, Bluebiotech International GmbH, Earthrise Nutritionals LLC, Marine Essence Biosciences, Coastal BioTech Ltd, MarineBioGroup and Biotal Marine.

Key Developments:

In October 2025, BASF SE and ANDRITZ Group have signed a license agreement for the use of BASF's proprietary gas treatment technology, OASE(R) blue, in a carbon capture project planned to be implemented in the city of Aarhus, Denmark. The project aims to capture approximately 435,000 tons of CO2 annually from the flue gases of a waste-to-energy plant for sequestration; the city of Aarhus has set itself the goal of becoming CO2-neutral by 2030.

In April 2023, AstaReal has partnered with i-ingredients, a leading importer and distributor of speciality ingredients, to help satisfy growing market demand for natural astaxanthin. As a result, nutraceutical producers in the UK and Ireland who wish to include AstaReal natural astaxanthin in their products can now rely on professional support with technical, regulatory and scientific issues.

Product Types Covered:

• Marine Enzymes
• Algae-Derived Biochemicals
• Bio-based Coatings & Corrosion Inhibitors
• Marine Nutraceuticals & Pharmaceuticals

Applications Covered:

• Coastal Restoration & Environmental Management
• Infrastructure Applications
• Aquaculture & Fisheries
• Healthcare & Therapeutic Applications

End Users Covered:

• Shipping & Marine Engineering
• Environmental Agencies
• Healthcare & Biotechnology
• Food & Beverage

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
• Saudi Arabia
• United Arab Emirates
• Qatar
• Israel
• Rest of Middle East
  • Africa
• South Africa
• Egypt
• Morocco
• Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global Coastal & Marine Biochemical Solutions Market, By Product Type

• 5.1 Marine Enzymes
• 5.2 Algae-Derived Biochemicals
• 5.3 Bio-based Coatings & Corrosion Inhibitors
• 5.4 Marine Nutraceuticals & Pharmaceuticals

6 Global Coastal & Marine Biochemical Solutions Market, By Application

• 6.1 Coastal Restoration & Environmental Management
• 6.2 Infrastructure Applications
• 6.3 Aquaculture & Fisheries
• 6.4 Healthcare & Therapeutic Applications

7 Global Coastal & Marine Biochemical Solutions Market, By End User

• 7.1 Shipping & Marine Engineering
• 7.2 Environmental Agencies
• 7.3 Healthcare & Biotechnology
• 7.4 Food & Beverage

8 Global Coastal & Marine Biochemical Solutions Market, By Geography

• 8.1 North America
  • 8.1.1 United States
  • 8.1.2 Canada
  • 8.1.3 Mexico
• 8.2 Europe
  • 8.2.1 United Kingdom
  • 8.2.2 Germany
  • 8.2.3 France
  • 8.2.4 Italy
  • 8.2.5 Spain
  • 8.2.6 Netherlands
  • 8.2.7 Belgium
  • 8.2.8 Sweden
  • 8.2.9 Switzerland
  • 8.2.10 Poland
  • 8.2.11 Rest of Europe
• 8.3 Asia Pacific
  • 8.3.1 China
  • 8.3.2 Japan
  • 8.3.3 India
  • 8.3.4 South Korea
  • 8.3.5 Australia
  • 8.3.6 Indonesia
  • 8.3.7 Thailand
  • 8.3.8 Malaysia
  • 8.3.9 Singapore
  • 8.3.10 Vietnam
  • 8.3.11 Rest of Asia Pacific
• 8.4 South America
  • 8.4.1 Brazil
  • 8.4.2 Argentina
  • 8.4.3 Colombia
  • 8.4.4 Chile
  • 8.4.5 Peru
  • 8.4.6 Rest of South America
• 8.5 Rest of the World (RoW)
  • 8.5.1 Middle East
    • 8.5.1.1 Saudi Arabia
    • 8.5.1.2 United Arab Emirates
    • 8.5.1.3 Qatar
    • 8.5.1.4 Israel
    • 8.5.1.5 Rest of Middle East
  • 8.5.2 Africa
    • 8.5.2.1 South Africa
    • 8.5.2.2 Egypt
    • 8.5.2.3 Morocco
    • 8.5.2.4 Rest of Africa

9 Strategic Market Intelligence

• 9.1 Industry Value Network and Supply Chain Assessment
• 9.2 White-Space and Opportunity Mapping
• 9.3 Product Evolution and Market Life Cycle Analysis
• 9.4 Channel, Distributor, and Go-to-Market Assessment

10 Industry Developments and Strategic Initiatives

• 10.1 Mergers and Acquisitions
• 10.2 Partnerships, Alliances, and Joint Ventures
• 10.3 New Product Launches and Certifications
• 10.4 Capacity Expansion and Investments
• 10.5 Other Strategic Initiatives

11 Company Profiles

• 11.1 BASF SE
• 11.2 AstaReal Co., Ltd.
• 11.3 Cyanotech Corporation
• 11.4 Marinomed Biotech AG
• 11.5 PharmaMar SA
• 11.6 Aker BioMarine ASA
• 11.7 Algatechnologies Ltd
• 11.8 CP Kelco U.S., Inc.
• 11.9 Euglena Co., Ltd.
• 11.10 GlycoMar Ltd.
• 11.11 Lonza Group
• 11.12 Marinova Pty Ltd
• 11.13 Bluebiotech International GmbH
• 11.14 Earthrise Nutritionals LLC
• 11.15 Marine Essence Biosciences
• 11.16 Coastal BioTech Ltd
• 11.17 MarineBioGroup
• 11.18 Biotal Marine

List of Tables

• Table 1 Global Coastal & Marine Biochemical Solutions Market Outlook, By Region (2023-2034) ($MN)
• Table 2 Global Coastal & Marine Biochemical Solutions Market Outlook, By Product Type (2023-2034) ($MN)
• Table 3 Global Coastal & Marine Biochemical Solutions Market Outlook, By Marine Enzymes (2023-2034) ($MN)
• Table 4 Global Coastal & Marine Biochemical Solutions Market Outlook, By Algae-Derived Biochemicals (2023-2034) ($MN)
• Table 5 Global Coastal & Marine Biochemical Solutions Market Outlook, By Bio-based Coatings & Corrosion Inhibitors (2023-2034) ($MN)
• Table 6 Global Coastal & Marine Biochemical Solutions Market Outlook, By Marine Nutraceuticals & Pharmaceuticals (2023-2034) ($MN)
• Table 7 Global Coastal & Marine Biochemical Solutions Market Outlook, By Application (2023-2034) ($MN)
• Table 8 Global Coastal & Marine Biochemical Solutions Market Outlook, By Coastal Restoration & Environmental Management (2023-2034) ($MN)
• Table 9 Global Coastal & Marine Biochemical Solutions Market Outlook, By Infrastructure Applications (2023-2034) ($MN)
• Table 10 Global Coastal & Marine Biochemical Solutions Market Outlook, By Aquaculture & Fisheries (2023-2034) ($MN)
• Table 11 Global Coastal & Marine Biochemical Solutions Market Outlook, By Healthcare & Therapeutic Applications (2023-2034) ($MN)
• Table 12 Global Coastal & Marine Biochemical Solutions Market Outlook, By End User (2023-2034) ($MN)
• Table 13 Global Coastal & Marine Biochemical Solutions Market Outlook, By Shipping & Marine Engineering (2023-2034) ($MN)
• Table 14 Global Coastal & Marine Biochemical Solutions Market Outlook, By Environmental Agencies (2023-2034) ($MN)
• Table 15 Global Coastal & Marine Biochemical Solutions Market Outlook, By Healthcare & Biotechnology (2023-2034) ($MN)
• Table 16 Global Coastal & Marine Biochemical Solutions Market Outlook, By Food & Beverage (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.